Category: topical
Tyrosinase inhibitor — blocks melanin synthesis in melanocytes. Topical 2% (OTC in some countries) and 4% (Rx) for melasma + post-inflammatory hyperpigmentation. Long-term high-strength use risks ochronosis (paradoxical darkening) — typically cycled.
TD: 24h